219 related articles for article (PubMed ID: 9384340)
1. Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid.
Dagan R; Muallem M; Melamed R; Leroy O; Yagupsky P
Pediatr Infect Dis J; 1997 Nov; 16(11):1060-4. PubMed ID: 9384340
[TBL] [Abstract][Full Text] [Related]
2. Safety and immunogenicity of tetravalent pneumococcal vaccines containing 6B, 14, 19F and 23F polysaccharides conjugated to either tetanus toxoid or diphtheria toxoid in young infants and their boosterability by native polysaccharide antigens.
Dagan R; Melamed R; Zamir O; Leroy O
Pediatr Infect Dis J; 1997 Nov; 16(11):1053-9. PubMed ID: 9384339
[TBL] [Abstract][Full Text] [Related]
3. Salivary anti-capsular antibodies in infants and children immunised with Streptococcus pneumoniae capsular polysaccharides conjugated to diphtheria or tetanus toxoid.
Korkeila M; Lehtonen H; Ahman H; Leroy O; Eskola J; Käyhty H
Vaccine; 2000 Jan; 18(13):1218-26. PubMed ID: 10649623
[TBL] [Abstract][Full Text] [Related]
4. Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines.
Anttila M; Eskola J; Ahman H; Käyhty H
J Infect Dis; 1998 Jun; 177(6):1614-21. PubMed ID: 9607841
[TBL] [Abstract][Full Text] [Related]
5. Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid conjugate vaccine is immunogenic in early infancy and able to induce immunologic memory.
Ahman H; Käyhty H; Lehtonen H; Leroy O; Froeschle J; Eskola J
Pediatr Infect Dis J; 1998 Mar; 17(3):211-6. PubMed ID: 9535248
[TBL] [Abstract][Full Text] [Related]
6. Dose dependency of antibody response in infants and children to pneumococcal polysaccharides conjugated to tetanus toxoid.
Ahman H; Käyhty H; Vuorela A; Leroy O; Eskola J
Vaccine; 1999 Jun; 17(20-21):2726-32. PubMed ID: 10418924
[TBL] [Abstract][Full Text] [Related]
7. Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants.
Rennels MB; Edwards KM; Keyserling HL; Reisinger KS; Hogerman DA; Madore DV; Chang I; Paradiso PR; Malinoski FJ; Kimura A
Pediatrics; 1998 Apr; 101(4 Pt 1):604-11. PubMed ID: 9521941
[TBL] [Abstract][Full Text] [Related]
8. Effect of a nonavalent conjugate vaccine on carriage of antibiotic-resistant Streptococcus pneumoniae in day-care centers.
Dagan R; Givon-Lavi N; Zamir O; Fraser D
Pediatr Infect Dis J; 2003 Jun; 22(6):532-40. PubMed ID: 12799510
[TBL] [Abstract][Full Text] [Related]
9. Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers.
Shinefield HR; Black S; Ray P; Chang I; Lewis N; Fireman B; Hackell J; Paradiso PR; Siber G; Kohberger R; Madore DV; Malinowski FJ; Kimura A; Le C; Landaw I; Aguilar J; Hansen J
Pediatr Infect Dis J; 1999 Sep; 18(9):757-63. PubMed ID: 10493334
[TBL] [Abstract][Full Text] [Related]
10. Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian children who participated in a 9-valent pneumococcal conjugate vaccine trial and in their younger siblings.
Cheung YB; Zaman SM; Nsekpong ED; Van Beneden CA; Adegbola RA; Greenwood B; Cutts FT
Pediatr Infect Dis J; 2009 Nov; 28(11):990-5. PubMed ID: 19536041
[TBL] [Abstract][Full Text] [Related]
11. Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine.
Dagan R; Melamed R; Muallem M; Piglansky L; Greenberg D; Abramson O; Mendelman PM; Bohidar N; Yagupsky P
J Infect Dis; 1996 Dec; 174(6):1271-8. PubMed ID: 8940218
[TBL] [Abstract][Full Text] [Related]
12. Functional antibodies elicited by an 11-valent diphtheria-tetanus toxoid-conjugated pneumococcal vaccine.
Puumalainen T; Ekström N; Zeta-Capeding R; Ollgren J; Jousimies K; Lucero M; Nohynek H; Käyhty H
J Infect Dis; 2003 Jun; 187(11):1704-8. PubMed ID: 12751027
[TBL] [Abstract][Full Text] [Related]
13. Serum and salivary anti-capsular antibodies in infants and children vaccinated with octavalent pneumococcal conjugate vaccines, PncD and PncT.
Nurkka A; Ahman H; Yaich M; Eskola J; Käyhty H
Vaccine; 2001 Oct; 20(1-2):194-201. PubMed ID: 11567764
[TBL] [Abstract][Full Text] [Related]
14. Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers.
Dagan R; Givon-Lavi N; Zamir O; Sikuler-Cohen M; Guy L; Janco J; Yagupsky P; Fraser D
J Infect Dis; 2002 Apr; 185(7):927-36. PubMed ID: 11920317
[TBL] [Abstract][Full Text] [Related]
15. Anticapsular serum antibody concentration and protection against pneumococcal colonization among children vaccinated with 7-valent pneumococcal conjugate vaccine.
Millar EV; O'Brien KL; Bronsdon MA; Madore D; Hackell JG; Reid R; Santosham M
Clin Infect Dis; 2007 May; 44(9):1173-9. PubMed ID: 17407035
[TBL] [Abstract][Full Text] [Related]
16. Nasopharyngeal pneumococcal carriage after combined pneumococcal conjugate and polysaccharide vaccination in children with a history of recurrent acute otitis media.
Veenhoven RH; Bogaert D; Schilder AG; Rijkers GT; Uiterwaal CS; Kiezebrink HH; van Kempen MJ; Dhooge IJ; Bruin J; Ijzerman EP; de Groot R; Kuis W; Hermans PW; Sanders EA
Clin Infect Dis; 2004 Oct; 39(7):911-9. PubMed ID: 15472839
[TBL] [Abstract][Full Text] [Related]
17. Serotype and molecular diversity of nasopharyngeal Streptococcus pneumoniae isolates from children before and after vaccination with the ten-valent pneumococcal conjugate vaccine (PCV10) in Ethiopia.
Sime WT; Aseffa A; Woldeamanuel Y; Brovall S; Morfeldt E; Henriques-Normark B
BMC Infect Dis; 2019 May; 19(1):409. PubMed ID: 31077141
[TBL] [Abstract][Full Text] [Related]
18. Antibody response to an eleven valent diphtheria- and tetanus-conjugated pneumococcal conjugate vaccine in Filipino infants.
Puumalainen T; Zeta-Capeding MR; Käyhty H; Lucero MG; Auranen K; Leroy O; Nohynek H
Pediatr Infect Dis J; 2002 Apr; 21(4):309-14. PubMed ID: 12075762
[TBL] [Abstract][Full Text] [Related]
19. Reduction of antibody response to an 11-valent pneumococcal vaccine coadministered with a vaccine containing acellular pertussis components.
Dagan R; Goldblatt D; Maleckar JR; Yaïch M; Eskola J
Infect Immun; 2004 Sep; 72(9):5383-91. PubMed ID: 15322036
[TBL] [Abstract][Full Text] [Related]
20. The short-term impact of each primary dose of pneumococcal conjugate vaccine on nasopharyngeal carriage: Systematic review and meta-analyses of randomised controlled trials.
Nicholls TR; Leach AJ; Morris PS
Vaccine; 2016 Feb; 34(6):703-13. PubMed ID: 26742947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
